ABBOTT LABORATORIES's gross profit margin for the first quarter of its fiscal year 2016 has decreased when compared to the same period a year ago. Sales and net income have dropped, underperforming the average competitor within its industry.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q1 FY16||Q1 FY15|
|Net Sales ($mil)||4885.0||4897.0|
|Net Income ($mil)||311.0||2292.0|
|Balance Sheet||Q1 FY16||Q1 FY15|
|Cash & Equiv. ($mil)||0.0||9849.0|
|Total Assets ($mil)||0.0||43095.0|
|Total Debt ($mil)||0.0||8903.0|
|Profitability||Q1 FY16||Q1 FY15|
|Gross Profit Margin||53.24||62.24|
|Return on Assets||0.0||9.74|
|Return on Equity||0.0||9.26|
|Debt||Q1 FY16||Q1 FY15|
|Share Data||Q1 FY16||Q1 FY15|
|Shares outstanding (mil)||1472.67||1488.76|
|Div / share||0.26||0.24|
|Book value / share||0.0||14.69|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||7314802.0||6689588.0|
BUY. This stock's P/E ratio indicates a significant discount compared to an average of 64.37 for the Health Care Equipment & Supplies industry and a premium compared to the S&P 500 average of 23.99. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. After reviewing these and other key valuation criteria, ABBOTT LABORATORIES proves to trade at a discount to investment alternatives within the industry.
|ABT 28.67||Peers 64.37||ABT NA||Peers 28.96|
Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.
ABT is trading at a significant discount to its peers.
Neutral. The P/CF ratio is the stock’s price divided by the sum of the company's cash flow from operations. It is useful for comparing companies with different capital requirements or financing structures.
Ratio not available.
|ABT 16.50||Peers 23.29||ABT 1.02||Peers 0.97|
Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.
ABT is trading at a discount to its peers.
Average. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
ABT trades at a valuation on par to its peers.
|ABT NA||Peers 4.79||ABT 6.01||Peers 30.16|
Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
Ratio not available.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, ABT is expected to significantly trail its peers on the basis of its earnings growth rate.
|ABT 2.92||Peers 4.57||ABT 0.01||Peers 20.88|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
ABT is trading at a significant discount to its industry on this measurement.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
ABT significantly trails its peers on the basis of sales growth
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.